Back to search

Article

SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice

2022-12-07

Abstract excerpt

<title>Abstract</title> <p>Heterozygous mutation targeting proline 95 in Serine/Arginine-rich Splicing Factor 2 (SRSF2), associates with V617F mutation in Janus Activated Kinase 2 (JAK2) in some myeloproliferative neoplasms (MPNs), most commonly primary myelofibrosis. To explore <italic>Srsf2</italic><sup>P95H</sup> interaction with <italic>Jak2</italic><sup>V617F</sup>, we generated Cre-inducible knock-in mice e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
41c6b0cc-4ccd-5d4a-80e4-555de857b3da
DOI
10.21203/rs.3.rs-2338471/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in miceDOI 10.21203/rs.3.rs-2338471/v1
Select a neighboring publication to make it the new centre.